Experiment: 6O0C

SOLUTION NMR

NMR Experiment
Experiment	Type	Sample Contents	Solvent	Ionic Strength	pH	Pressure	Temperature (K)	Spectrometer
1	2D 1H-13C HSQC	600 uM U-[15N, 12C, 2H] 13Ce Met 13Cb Ala 13Cd1 Ile 13Cd2 Leu 13Cg2 Val k170_MAI(LV)proS	95% H2O/5% D2O	100mM NaCl mM	6.2	1 atm	310.15	Bruker AVANCE III 800
2	3D CM-CMHM NOESY	600 uM U-[15N, 12C, 2H] 13Ce Met 13Cb Ala 13Cd1 Ile 13Cd2 Leu 13Cg2 Val k170_MAI(LV)proS	95% H2O/5% D2O	100mM NaCl mM	6.2	1 atm	310.15	Bruker AVANCE III 800
3	3D CM-NHN NOESY	600 uM U-[15N, 12C, 2H] 13Ce Met 13Cb Ala 13Cd1 Ile 13Cd2 Leu 13Cg2 Val k170_MAI(LV)proS	95% H2O/5% D2O	100mM NaCl mM	6.2	1 atm	310.15	Bruker AVANCE III 800
4	3D HNHa-CMHM NOESY	600 uM U-[15N, 12C, 2H] 13Ce Met 13Cb Ala 13Cd1 Ile 13Cd2 Leu 13Cg2 Val k170_MAI(LV)proS	95% H2O/5% D2O	100mM NaCl mM	6.2	1 atm	310.15	Bruker AVANCE III 800
6	2D 1H-15N HSQC	400 uM U-[15N, 13C, 2H] k170_ILVstar	95% H2O/5% D2O	100mM NaCl mM	6.2	1 atm	310.15	Bruker AVANCE III 800
7	3D HNCO	400 uM U-[15N, 13C, 2H] k170_ILVstar	95% H2O/5% D2O	100mM NaCl mM	6.2	1 atm	310.15	Bruker AVANCE III 800
9	3D HNCA	400 uM U-[15N, 13C, 2H] k170_ILVstar	95% H2O/5% D2O	100mM NaCl mM	6.2	1 atm	310.15	Bruker AVANCE III 800
8	3D HNCACB	400 uM U-[15N, 13C, 2H] k170_ILVstar	95% H2O/5% D2O	100mM NaCl mM	6.2	1 atm	310.15	Bruker AVANCE III 800

NMR Spectrometer Information
Spectrometer	Manufacturer	Model	Field Strength
1	Bruker	AVANCE III	800

NMR Refinement
Method	Details	Software
simulated annealing		Rosetta

NMR Ensemble Information
Conformer Selection Criteria	back calculated data agree with experimental NOESY spectrum
Conformers Calculated Total Number	5000
Conformers Submitted Total Number	10
Representative Model	1 (fewest violations)

Computation: NMR Software
#	Classification	Version	Software Name	Author
1	refinement	Rosetta		Rohl CA, Strauss CE, Misura KM, Baker D
2	data analysis	Sparky		Goddard
5	processing	NMRPipe		Delaglio, Grzesiek, Vuister, Zhu, Pfeifer and Bax
3	chemical shift assignment	Sparky		Goddard
4	structure calculation	Rosetta		Rohl CA, Strauss CE, Misura KM, Baker D

RCSB PDB Core Operations are funded by the U.S. National Science Foundation (DBI-2321666), the US Department of Energy (DE-SC0019749), and the National Cancer Institute, National Institute of Allergy and Infectious Diseases, and National Institute of General Medical Sciences of the National Institutes of Health under grant R01GM157729.